Substance Use Disorder
The Food and Drug Administration yesterday approved a mobile medical application to help increase retention in outpatient treatment programs for opioid use disorder.
More than 220 organizations, including the AHA, Friday urged Senate committee leaders to consider the Overdose Prevention and Patient Safety Act (H.R. 6082) and encourage Senate leadership to bring the bill to the floor for a vote during the lame-duck session.
Also in this weekly roundup of health care news: When rural hospitals close, the health implications are significant; the VA pilots behavioral health integrated model; and a small drug company tests waters of cholesterol medicine market.
This AHA Legislative Advisory offers a detailed summary of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018, which President Trump signed into law Oct. 24.
Gov. Northam understands that any meaningful discussion of overcoming the opioid problem must go beyond listing programs or citing statistics.
UnitedHealth Group, the nation's largest health insurer, and Genoa Healthcare, one of the nation's largest pharmacy chains, are teaming up in a move that could bring significant cost savings and improved operational efficiency in caring for psychiatric patients and those with substance use…
The House of Representatives today passed by a vote of 393-8 the final version of the Opioid Crisis Response Act (H.R. 6).
The Substance Abuse and Mental Health Services Administration this week awarded American Indian and Alaska Native tribes $50 million in grants to combat opioid overdoses.
The Substance Abuse and Mental Health Services Administration yesterday awarded grants to two tribal organizations in Alaska to increase access to mental health services and medication-assisted treatment for opioid use disorders for teens and young adults.
U.S. Surgeon General Jerome Adams today released a report highlighting actions individuals and families, health care providers, educators, employers, researchers and communities can take to prevent and treat opioid use disorders and reduce overdose deaths.